Bivalent RSV prefusion F vaccination elicits effective neutralization of contemporary and monoclonal antibody-resistant RSV strains.

NPJ Vaccines · 2026 · PMC13133364 · PMID 41832196

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

marginally significantp = 0.08so close (0.05 < p ≤ 0.1)

There was a marginally significant ( p = 0.08) effect between subgroup and nirsevimab concentration, when evaluated using an ANOVA, with a significant difference observed at 13.6 μg /mL nirsevimab ( p = 0.007) (Supplementary Fig. 5 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.